Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Clinical trial NCT02824029 · COMPLETED
Trial details
- NCT number
- NCT02824029
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2023-05-12
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.